Understand the source comparison
Best Research Peptides for PCOS Research: Pathway Comparison
GLP-1 Agonists (Semaglutide, Tirzepatide) Incretin receptor activation → insulin secretion, gastric emptying delay Hyperinsulinemia, androgen excess Strong clinical translation. Phase 3 data in PCOS populations Best for insulin-androgen axis studies with direc
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GLP-1 Agonists (Semaglutide, Tirzepatide)
- Incretin receptor activation → insulin secretion, gastric emptying delay
- Hyperinsulinemia, androgen excess
- Strong clinical translation. Phase 3 data in PCOS populations
- Best for insulin-androgen axis studies with direct human relevance
- MOTS-c
- AMPK activation → insulin-independent glucose uptake
- Insulin resistance independent of obesity
- Strong mechanistic clarity. Single-pathway target
- Best for lean PCOS models where obesity confounds insulin studies
- BPC-157
- NF-kB inhibition → reduced inflammatory cytokine expression
- Chronic inflammation, impaired follicular development
- Moderate. Animal data robust, human PCOS data limited
- Best for inflammation-ovarian function crosstalk protocols
- Thymosin Beta-4
- Actin sequestration → reduced inflammatory signaling in adipose tissue
- Adipose-derived systemic inflammation
- Moderate. Requires adipose tissue sampling
- Best for studies examining adipose-ovarian inflammatory pathways
- Humanin
- STAT3 signaling → mitochondrial oxidative stress reduction
- Granulosa cell energy deficits, anovulation
- Strong theoretical basis. Limited direct PCOS research
- Best for exploratory studies linking mitochondrial health to ovarian function
- SS-31 (Elamipretide)
- Cardiolipin binding → cristae stabilization, ATP synthesis
- Mitochondrial dysfunction in reproductive tissues
- Strong. Documented ATP improvement in metabolic tissues
- Best for mechanistic studies isolating mitochondrial function from biogenesis